VOX.WAR Voxel S.A.

Healthcare Biotechnology Warsaw Stock Exchange
157.60 PLN
Close of Oct 29, 2026
92.40 161.20
Market cap
PLN 1.66B
P/E
14.2x
P/B
3.74x
ROE
29.3%
Dividend yield
2.88%
Fundamental score
3.6/5

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is VOX.WAR undervalued?

Graham number
Price157.60
Graham value102.69
Premium53.5%

VOX.WAR trades 53.5% above its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Voxel S.A. fundamental analysis

16 of 22 checks passed

ROE 2/2

High return on equity (29.3%), above 20%.

ROA 1/1

Return on assets (17.0%) is above the industry median (-18.6%).

Profit Consistency 2/2

Profitable for 10 consecutive years.

Earnings Growth 5Y 1/1

Earnings per share grew over the past 5 years.

Earnings Acceleration 0/1

Last year's EPS growth (2.2%) is not above the 5-year average (23.7% a year).

Earnings Growth vs Industry 0/1

Last year's EPS growth (2.2%) is below the industry median (2.6%).

Revenue Growth 2/2

Revenue grew 12.1% a year over the past 3 years.

Short-term Liquidity 1/1

Current assets cover short-term liabilities.

Long-term Liabilities 1/1

Current assets cover long-term liabilities.

Debt to Equity 2/2

Low debt to equity (36.1%), 40% or less.

Debt Trend 1/1

Debt to equity has not risen over the past 5 years.

Debt Coverage 1/1

Operating cash flow covers 20% of total debt.

Interest Coverage 1/1

EBIT is 20.4x against interest expense, well covered.

PE vs Market 0/1

PE (14.2x) is above the market median (11.6x).

PE vs Industry 1/1

PE (14.2x) is below the industry median (18.6x).

PBV 0/1

Price to book (3.7x) is above the industry median (3.6x).

Graham Number 0/1

The price is above the Graham number (PE x PB = 53.0, limit 22.5).

PEG 1/1

PEG on 5-year earnings growth is 0.60, growth is cheap.

Dividend Yield 1/2

Dividend yield (2.9%) is above the bottom 25% of dividend payers in the market.

Dividend Stability 0/2

Dividends were not paid steadily for the past 5 years.

Dividend Growth 1/1

Dividends paid grew over the past 5 years.

Payout Ratio 1/1

Payout ratio is 48.4%, covered by earnings.

Each check is worth 1 or 2 points by how much it says about the quality of the company. The score is the share of points earned, out of 5. Ask AI to explain this score

Voxel S.A. stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Voxel S.A.

Voxel S.A. provides medical services in Poland. The company offers imaging diagnostics services, including reimbursed, commercial, and private patient examinations; teleradiology services; and clinical/pharmaceutical trials. It is also involved in the sale of radiopharmaceuticals, and the leasing of land. Voxel S.A. was incorporated in 2005 and is headquartered in Kraków, Poland.

Full company profile